Theresa L Whiteside Selected Research

Theresa L Whiteside Research Topics

Disease

172	Neoplasms (Cancer) 01/2022 - 02/2002
50	Squamous Cell Carcinoma of Head and Neck 08/2021 - 06/2002
26	Head and Neck Neoplasms (Head and Neck Cancer) 11/2020 - 04/2002
20	Melanoma (Melanoma, Malignant) 10/2021 - 07/2002
9	Glioma (Gliomas) 01/2022 - 08/2003
9	Disease Progression 06/2021 - 06/2008
9	Carcinoma (Carcinomatosis) 01/2018 - 12/2002
8	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2003
7	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2003
7	Leukemia 01/2019 - 01/2015
6	Inflammation (Inflammations) 04/2022 - 01/2007
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2013 - 01/2005
5	Carcinogenesis 12/2019 - 03/2005
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017 - 01/2010
5	Infections 12/2015 - 10/2004
5	Ovarian Neoplasms (Ovarian Cancer) 03/2012 - 08/2003
4	Human Influenza (Influenza) 08/2012 - 06/2002
3	Lymphatic Metastasis 06/2020 - 05/2006
3	Glioblastoma (Glioblastoma Multiforme) 06/2020 - 08/2003
2	Lung Neoplasms (Lung Cancer) 10/2020 - 03/2003
2	Pathologic Complete Response 08/2020 - 05/2009
2	Lymphoma (Lymphomas) 01/2020 - 04/2016
2	Viremia 05/2016 - 02/2008
2	Residual Neoplasm 01/2016 - 11/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 01/2013
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2012 - 06/2012

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
32	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2003
31	AntigensIBA 01/2021 - 03/2002
31	Peptides (Polypeptides)IBA 09/2017 - 02/2002
26	CytokinesIBA 01/2018 - 02/2003
26	VaccinesIBA 05/2016 - 07/2002
23	EpitopesIBA 07/2019 - 02/2002
14	Adenosine (Adenocard)FDA LinkGeneric 07/2021 - 10/2009
12	Biological ProductsIBA 01/2018 - 02/2002
9	LigandsIBA 12/2019 - 02/2002
9	Interleukin-2 (IL2)IBA 12/2011 - 07/2002
8	Cancer VaccinesIBA 01/2016 - 02/2002
7	MicroRNAs (MicroRNA)IBA 11/2021 - 04/2016
6	AntibodiesIBA 01/2021 - 09/2009
6	Messenger RNA (mRNA)IBA 11/2020 - 03/2004
6	IRX 2IBA 01/2018 - 04/2011
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 04/2009
6	EnzymesIBA 01/2017 - 02/2003
6	Interleukin-10 (Interleukin 10)IBA 04/2016 - 09/2007
6	Neoplasm Antigens (Tumor Antigens)IBA 05/2014 - 10/2004
6	Interleukin-15 (Interleukin 15)IBA 09/2011 - 09/2005
6	Fas Ligand Protein (Fas Ligand)IBA 09/2009 - 02/2002
5	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 11/2021 - 01/2013
5	Adenosine Triphosphate (ATP)IBA 07/2021 - 09/2010
5	Nucleic AcidsIBA 01/2021 - 01/2015
5	Protein Subunit VaccinesIBA 07/2019 - 03/2012
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 04/2005
4	Tumor Biomarkers (Tumor Markers)IBA 06/2021 - 11/2009
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2006
4	Small Interfering RNA (siRNA)IBA 11/2019 - 09/2007
4	InterferonsIBA 01/2019 - 09/2002
4	gallium arsenide (GaAs)IBA 12/2016 - 12/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 07/2002
4	Annexin A5IBA 12/2012 - 01/2003
4	Prostaglandins EIBA 02/2012 - 09/2007
4	HLA-A*02:01 antigenIBA 11/2007 - 10/2004
4	Histocompatibility Antigens Class IIBA 07/2006 - 11/2003
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2006 - 12/2002
3	Monoclonal AntibodiesIBA 01/2015 - 07/2009
3	Pharmaceutical PreparationsIBA 12/2014 - 07/2003
3	Muromonab-CD3 (Muromonab CD3)FDA Link 12/2011 - 02/2009
3	Interleukin-5 (Interleukin 5)IBA 09/2009 - 03/2002
3	HLA-DR Antigens (HLA-DR)IBA 09/2008 - 02/2006
3	HLA-A Antigens (HLA-A)IBA 10/2007 - 12/2005
2	Glycoproteins (Glycoprotein)IBA 04/2022 - 07/2012
2	ProteomeIBA 01/2021 - 01/2019
2	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 12/2019 - 11/2018
2	Cetuximab (Erbitux)FDA Link 01/2019 - 06/2015
2	poly ICLCIBA 01/2016 - 01/2011
2	Interleukin-8 (Interleukin 8)IBA 06/2015 - 04/2009
2	Lysine (L-Lysine)FDA Link 07/2014 - 01/2011
2	Poly I-CIBA 07/2014 - 01/2011
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2014 - 01/2011
2	Dinoprostone (PGE2)FDA Link 01/2014 - 01/2013
2	Protein Isoforms (Isoforms)IBA 12/2012 - 10/2011
2	LipopolysaccharidesIBA 12/2011 - 04/2009
2	ErbB Receptors (EGF Receptor)IBA 10/2011 - 06/2009
2	ProstaglandinsIBA 09/2011 - 09/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2011 - 09/2007
2	ChemokinesIBA 06/2009 - 05/2006
2	NF-kappa B (NF-kB)IBA 04/2009 - 01/2007
2	InterleukinsIBA 04/2009 - 12/2007
2	Interleukin-4 (Interleukin 4)IBA 12/2007 - 08/2003
2	Sirolimus (Rapamycin)FDA Link 12/2007 - 09/2007
2	Chemokine ReceptorsIBA 05/2006 - 03/2004
2	peptide AIBA 04/2006 - 06/2002

Therapy/Procedure

75	Therapeutics 01/2022 - 04/2002
36	Immunotherapy 01/2022 - 06/2002
8	Drug Therapy (Chemotherapy) 04/2021 - 08/2004
5	Radiotherapy 01/2019 - 12/2004
4	Biological Therapy 05/2011 - 12/2002
2	Art Therapy 05/2016 - 02/2008
2	Chemoprevention 02/2013 - 11/2007
2	Ligation 04/2009 - 10/2003